Literature DB >> 21788711

Splenic rupture in dengue hemorrhagic fever: report of a case and review.

Luísa Salles de Moura Mendonça1, Maria Lígia de Moura Mendonça, Nathalia Parrode, Machado Barbosa, Rhanderson Miller Nascimento Cardoso, João Alves de Araújo-Filho.   

Abstract

Dengue is currently the most important arboviral disease in the world, particularly in tropical countries in which the environmental conditions favor the development and proliferation of the mosquito vector. Dengue hemorrhagic fever presents in two phases: an initial phase, which is characterized by sudden onset of fever and a variety of nonspecific signs and symptoms, and a critical phase, which is characterized by the recovery from fever and development of hemorrhagic symptoms and circulatory insufficiency. This report documents a case of splenic rupture in a patient with dengue hemorrhagic fever who developed hypovolemic shock and subsequently died. Although splenic rupture is a known complication of other acute infections, it is a rare complication of dengue; therefore, it may be misdiagnosed. In the case described here, the poor outcome mainly resulted from the sudden onset of complications; the patient died of splenic rupture less than 24 h after admission, and the cause of death was confirmed at necropsy.

Entities:  

Mesh:

Year:  2011        PMID: 21788711

Source DB:  PubMed          Journal:  Jpn J Infect Dis        ISSN: 1344-6304            Impact factor:   1.362


  3 in total

1.  Spontaneous splenic rupture during the recovery phase of dengue fever.

Authors:  W T T de Silva; M Gunasekera
Journal:  BMC Res Notes       Date:  2015-07-02

2.  Spontaneous splenic rupture: A rare presentation of dengue fever.

Authors:  Mainak Mukhopadhyay; Nandini Chatterjee; Pranab Maity; Kartik Patar
Journal:  Indian J Crit Care Med       Date:  2014-02

3.  Evidence of dengue virus replication in a non-traumatic spleen rupture case.

Authors:  Luiz José de Souza; João de Azevedo; Liza Ingride Acha Kohler; Lorena de Freitas Barros; Mariana Arêdes Lima; Emiliana Mandarano Silva; Ronaldo Mohana-Borges; Priscila Conrado Guerra Nunes; Marciano Viana Paes
Journal:  Arch Virol       Date:  2017-08-14       Impact factor: 2.574

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.